Farré Ramon, Gozal David, Montserrat Josep M
Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.
CIBER de Enfermedades Respiratorias, 28029 Madrid, Spain.
J Clin Med. 2021 Apr 1;10(7):1453. doi: 10.3390/jcm10071453.
In the treatment of obstructive sleep apnea (OSA), the current standard of "CPAP titration" in the laboratory or at home is a resource demanding and costly approach that, in developed economies, markedly augments healthcare costs and in low resource economies precludes access to care altogether. Here, we discuss that current guidelines for titration of CPAP could be obviated by taking a different route that in many ways is similar to the institution of treatment in many other medical conditions. To this effect, we present novel population based data from 16,780 patients, showing that after individualized and labor-intensive and expensive CPAP titration, 86.4% of OSA patients are treated with nasal pressure settings within the range of 9 ± 2 cmHO, and review the literature to justify the potential adoption of a standard therapeutic CPAP setting as the initial intervention which would be subsequently followed by any necessary adjustments in only a minority of patients who would not derive the necessary benefit from such standardized intervention. Assuming an 80-85% success rate as derived from our analyses, our personal view if extensively adopted could radically reduce healthcare costs and enable markedly improve access to diagnostics.
在阻塞性睡眠呼吸暂停(OSA)的治疗中,目前在实验室或家中进行“持续气道正压通气(CPAP)滴定”的标准方法既耗费资源又成本高昂,在发达经济体中显著增加了医疗成本,而在资源匮乏的经济体中则完全无法获得治疗。在此,我们讨论通过采用一种在许多方面类似于许多其他医疗状况治疗方法的不同途径,可以避免当前CPAP滴定指南。为此,我们展示了来自16780名患者的基于人群的新数据,表明经过个体化、耗费人力且昂贵的CPAP滴定后,86.4%的OSA患者接受的鼻压力设置在9±2厘米水柱范围内,并回顾了文献以证明采用标准治疗CPAP设置作为初始干预的潜在合理性,随后仅对少数无法从此类标准化干预中获得必要益处的患者进行任何必要调整。假设我们的分析得出的成功率为80 - 85%,我们个人认为,如果广泛采用,可能会从根本上降低医疗成本并显著改善诊断的可及性。